Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of MBF-015 in Huntington's Disease Patients
Clinical trial NCT06469853 · COMPLETED
Trial details
- NCT number
- NCT06469853
- Sponsor
- Medibiofarma S.L.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2024-12-04
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.